GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » 6-1 Month Momentum %

VRAX (Virax Biolabs Group) 6-1 Month Momentum % : -18.13% (As of Apr. 09, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-04-09), Virax Biolabs Group's 6-1 Month Momentum % is -18.13%.

The industry rank for Virax Biolabs Group's 6-1 Month Momentum % or its related term are showing as below:

VRAX's 6-1 Month Momentum % is ranked worse than
54.98% of 1466 companies
in the Biotechnology industry
Industry Median: -14.185 vs VRAX: -18.13

Competitive Comparison of Virax Biolabs Group's 6-1 Month Momentum %

For the Biotechnology subindustry, Virax Biolabs Group's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Virax Biolabs Group's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Virax Biolabs Group's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Virax Biolabs Group's 6-1 Month Momentum % falls into.


;
;

Virax Biolabs Group  (NAS:VRAX) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Virax Biolabs Group  (NAS:VRAX) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Virax Biolabs Group 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Virax Biolabs Group Business Description

Traded in Other Exchanges
N/A
Address
Bo’Ness Road Newhouse, BioCity Glasgow, London, GBR, ML1 5UH
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.